5-Amino-1MQ vs LIPO-C: Research Comparison Key Takeaways 5-Amino-1MQ inhibits NNMT to preserve NAD+ in adipose tissue, shifting cellular metabolism toward mitochondrial oxidation and thermogenesis
However, a handful of small-scale CJC-1295 studies have centered on its impact on GH secretion, the effects of cumulative doses, and the frequency of adverse events [7]
These peptides may be available through compounding pharmacies under specific circumstances or through research chemical suppliers, but such availability does not confer regulatory approval or imply safety and efficacy for human therapeutic use
Potential risks include hormone imbalances, effects on blood sugar levels, and increased IGF-1 (insulin-like growth factor) levels, which may lead to other risks over time
Potential of these effects may be heightened in patients with breast cancer treated with hepatically metabolized chemotherapeutics (e.g., cyclophosphamide, paclitaxel, anthracyclines) or tyrosine kinase inhibitors in which drug-drug interaction-based elevation or lowering of enzyme activity can result in supra-therapeutic drug concentrations, accumulation of toxic metabolites and compromised detoxification of reactive oxygen species facilitating hepatocellular distress